Noxopharm soars after revealing prostate cancer breakthrough
SYDNEY: Biotech Noxopharm jumped as much as 7.6 per cent today after the cancer treatments
SYDNEY: Biotech Noxopharm jumped as much as 7.6 per cent today after the cancer treatments
FEATURED
Kit home to lower costs for multigenerational housing
Best retirement housing design for Global Awards shortlisted
Strong demand for luxury over-55s living starting to emerge
Boomers now direct spending to kids and grandkids
New opportunities starting to emerge in senior housing market
Multigenerational housing to be integrated into tech hub
INNOVATION
